Ranbaxy Laboratories Ltd
- All
- News
- Videos
-
Ex-Ranbaxy Promoter Fined Nearly 18 Crore Over Court Disobedience
The Delhi High Court Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million Singapore dollars, which he obtained by selling his shares in a company in violation of court's direction.
-
Sun Pharmaceutical Wins US Approval to Buy Ranbaxy
India's Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the US Federal Trade Commission (FTC) said on Friday.
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
US FDA bans more products from Ranbaxy
The U.S. Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Ltd from entering the United States due to manufacturing violations.
-
Suspected hair in tablet cited in Ranbaxy import alert
During a visit to a facility of leading drugmaker Ranbaxy Laboratories Ltd last year, US inspectors found that a black fibre embedded in a tablet may have been a hair from an employee's arm, according to documents seen by Reuters.
-
Ranbaxy to pay $500 million in US lawsuit settlement
Generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the US Department of Justice.
-
Ranbaxy Laboratories recalls generic Lipitor in United States
Drugmaker Ranbaxy Laboratories Ltd has recalled its generic version of Pfizer Inc's cholesterol-lowering drug Lipitor in the United States after certain batches were found to contain glass particles.
-
Ex-Ranbaxy Promoter Fined Nearly 18 Crore Over Court Disobedience
The Delhi High Court Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million Singapore dollars, which he obtained by selling his shares in a company in violation of court's direction.
-
Sun Pharmaceutical Wins US Approval to Buy Ranbaxy
India's Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the US Federal Trade Commission (FTC) said on Friday.
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
US FDA bans more products from Ranbaxy
The U.S. Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Ltd from entering the United States due to manufacturing violations.
-
Suspected hair in tablet cited in Ranbaxy import alert
During a visit to a facility of leading drugmaker Ranbaxy Laboratories Ltd last year, US inspectors found that a black fibre embedded in a tablet may have been a hair from an employee's arm, according to documents seen by Reuters.
-
Ranbaxy to pay $500 million in US lawsuit settlement
Generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the US Department of Justice.
-
Ranbaxy Laboratories recalls generic Lipitor in United States
Drugmaker Ranbaxy Laboratories Ltd has recalled its generic version of Pfizer Inc's cholesterol-lowering drug Lipitor in the United States after certain batches were found to contain glass particles.
